Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Cardiol. Jun 26, 2025; 17(6): 106717
Published online Jun 26, 2025. doi: 10.4330/wjc.v17.i6.106717
Table 3 Laboratory blood tests of the included patients
Variable
Transient improvement (n = 39)
Sustained improvement (n = 136)
P value
Baseline (Echo-1)
NT-pro-BNP (pg/mL)5106.63 ± 6035.19 (n = 27)4730.48 ± 6792.82 (n = 93)0.80
Hemoglobin (g/dL) 13.16 ± 2.22 (n = 38)14.20 ± 12.89 (n = 132)0.62
Urea (mmol/L)8.16 ± 4.53 (n = 38)7.15 ± 4.17 (n = 133)0.20
Creatinine (µmol/L)120.03 ± 56.87 (n = 38)113.55 ± 114.84 (n = 132)0.74
eGFR (mL/min)66.47 ± 27.79 (n = 38)79.68 ± 33.27 (n = 132)0.03
HbA1c (%)8.38 ± 2.34 (n = 26)7.54 ± 2.19 (n = 102)0.09
LDL-C (mmol/L)2.69 ± 0.92 (n = 35)2.57 ± 1.18 (n = 120)0.56
Iron (µmol/L)8.87 ± 3.69 (n = 10)10.43 ± 6.49 (n = 37)0.47
TSAT (%)16.77 ± 5.42 (n = 10)20.37 ± 15.74 (n = 35)0.48
Ferritin (ug/L)325.75 ± 347.95 (n = 8)208.50 ± 277.71 (n = 30)0.32
TSH (pmol/L)1.76 ± 1.51 (n = 22)2.38 ± 2.18 (n = 92)0.21
T4 (mIU/L)13.51 ± 1.70 (n = 23)14.87 ± 3.58 (n = 87)0.08
Second follow-up (Echo-3)
NT-pro-BNP (pg/mL)7672.15 ± 13459.32 (n = 27)3184.52 ± 6564.79 (n = 81)0.11
Hemoglobin (g/dL)12.23 ± 2.25 (n = 37)12.87 ± 2.08 (n = 120)0.11
Urea (mmol/L)10.28 ± 7.27 (n = 38)8.50 ± 8.94 (n = 125)0.26
Creatinine (µmol/L)142.84 ± 88.49 (n = 38)127.25 ± 126.01 (n = 128)0.48
eGFR (mL/min)59.89 ± 28.49 (n = 38)70.35 ± 29.24 (n = 127)0.05
HbA1c (%)7.66 ± 2.04 (n = 33)7.90 ± 4.88 (n = 103)0.79
LDL-C (mmol/L)1.81 ± 0.99 (n = 33)2.03 ± 0.93 (n = 99)0.25
Iron (µmol/L)9.64 ± 4.33 (n = 18)11.23 ± 6.24 (n = 41)0.33
TSAT (%)17.44 ± 8.69 (n = 18)23.48 ± 16.53 (n = 41)0.15
Ferritin (ug/L)276.17 ± 489.76 (n = 14)244.41 ± 429.58 (n = 30)0.83
TSH (pmol/L)2.43 ± 1.45 (n = 22)3.22 ± 3.12 (n = 83)0.26
T4 (mIU/L)15.73 ± 2.23 (n = 19)15.05 ± 3.86 (n = 73)0.46